Our and other recent studies have documented that polymorphisms located within genes encoding cytokines regulated by NF-κB, IL-17A and IL-17F [7,8,9], or by TNF-α and its receptor [10], may be associated with RA susceptibility and response to therapy with TNF-α inhibitors. Here, TNF is linked to rheumatoid arthritis.